Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery
Current Oncology · 26.01.2026 · 33 (2) · 71
DOI: 10.3390/curroncol33020071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 26.01.2026. Verfasst von Yossi Tzur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ICRF Montreal, Israel Cancer Research Fund.
Abstract (Originalsprache)
Background
Complete cytoreduction remains the primary surgical objective in advanced ovarian cancer and concerns persist that robotic surgery may result in distinct recurrence patterns and worse oncologic outcomes due to technical limitations, such as the use of pneumoperitoneum, the restricted visualization, and the lack of tactile evaluation.
Methods
We retrospectively identified 125 consecutive patients with advanced epithelial ovarian cancer who attained the best outcome surgery can achieve, and compared the outcome of these patients based on whether complete cytoreduction was achieved by laparotomy or robotic surgery. The primary objective was to compare recurrence patterns and secondary analyses assessed perioperative, postoperative, and survival outcomes.
Results
Among 125 patients who had complete cytoreduction (78 robotic; 47 open), baseline characteristics were largely comparable, except for higher rates of interval cytoreduction (84.6% vs. 61.7%, p < 0.01) and more PARP inhibitor use (19.2% vs. 6.4%, p = 0.048) in the robotic group. Recurrence patterns did not differ. Operative and postoperative outcomes were likewise comparable. Median disease-free and overall survival were longer in the robotic group.
Conclusions
Among patients achieving complete cytoreduction, recurrence patterns and oncologic outcomes were comparable between robotic and open surgery, suggesting that the route of attaining complete cytoreduction did not influence the outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
- Lady Davis Institute for Cancer Research, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
ORCID-Profile: Yossi Tzur, Yoav Brezinov, Melica Nourmoussavi Brodeur, Shannon Salvador, Walter H Gotlieb
Förderung
- ICRF Montreal
- Israel Cancer Research Fund
Zitieren
APA
Tzur, Y., Brezinov, Y., Bar-Noy, T., Yasmeen, A., Brodeur, M. N., Salvador, S., Gotlieb, W. H., & Lau, S. (2026). Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery. Current Oncology, 33(2), 71. https://doi.org/10.3390/curroncol33020071
Vancouver
Tzur Y, Brezinov Y, Bar-Noy T, Yasmeen A, Brodeur MN, Salvador S, et al. Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery. Current Oncology. 2026;33(2):71. doi:10.3390/curroncol33020071
BibTeX
@article{Tzur2026,
author = {Tzur, Yossi and Brezinov, Yoav and Bar-Noy, Tomer and Yasmeen, Amber and Brodeur, Melica Nourmoussavi and Salvador, Shannon and Gotlieb, Walter H and Lau, Susie},
title = {Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {2},
pages = {71},
doi = {10.3390/curroncol33020071}
}
EUVIMED